GB201004415D0 - Increasing the selectivity of the anticancer drug cyclophamide - Google Patents

Increasing the selectivity of the anticancer drug cyclophamide

Info

Publication number
GB201004415D0
GB201004415D0 GBGB1004415.4A GB201004415A GB201004415D0 GB 201004415 D0 GB201004415 D0 GB 201004415D0 GB 201004415 A GB201004415 A GB 201004415A GB 201004415 D0 GB201004415 D0 GB 201004415D0
Authority
GB
United Kingdom
Prior art keywords
cyclophamide
selectivity
increasing
anticancer drug
anticancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1004415.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB201004415D0 publication Critical patent/GB201004415D0/en
Ceased legal-status Critical Current

Links

GBGB1004415.4A 2010-02-06 2010-03-17 Increasing the selectivity of the anticancer drug cyclophamide Ceased GB201004415D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1001959.4A GB201001959D0 (en) 2010-02-06 2010-02-06 Formulations of generic drugs against cancer and infectious diseases

Publications (1)

Publication Number Publication Date
GB201004415D0 true GB201004415D0 (en) 2010-05-05

Family

ID=42082589

Family Applications (17)

Application Number Title Priority Date Filing Date
GBGB1001959.4A Ceased GB201001959D0 (en) 2010-02-06 2010-02-06 Formulations of generic drugs against cancer and infectious diseases
GBGB1002941.1A Ceased GB201002941D0 (en) 2010-02-06 2010-02-22 Delaying the development of resistances to anticancer,antibacterial and some other drugs
GBGB1003119.3A Ceased GB201003119D0 (en) 2010-02-06 2010-02-24 Methods for delaying or overcoming bacterial drug resistance to beta-lactam and other antibiotics
GBGB1003116.9A Ceased GB201003116D0 (en) 2010-02-06 2010-02-24 Reversing resistance to anticancer, antibacterial and some other drugs
GBGB1003514.5A Ceased GB201003514D0 (en) 2010-02-06 2010-03-03 Improvements in antibacterial drugs
GBGB1003509.5A Ceased GB201003509D0 (en) 2010-02-06 2010-03-03 Delaying the development of resistances to anticancer,antibacterial and some other drugs
GBGB1003676.2A Ceased GB201003676D0 (en) 2010-02-06 2010-03-05 Overcoming beta-lactam drug resistance
GBGB1003782.8A Ceased GB201003782D0 (en) 2010-02-06 2010-03-08 A wide-spectrum chemotherapy of cancers and baterial diseases
GBGB1003935.2A Ceased GB201003935D0 (en) 2010-02-06 2010-03-10 Improvements in antibacterial drugs
GBGB1004209.1A Ceased GB201004209D0 (en) 2010-02-06 2010-03-15 Low toxic 5-fluorouracil chemotherapy
GBGB1004328.9A Ceased GB201004328D0 (en) 2010-02-06 2010-03-16 Increasing the efficacy of anticancer drugs
GBGB1004415.4A Ceased GB201004415D0 (en) 2010-02-06 2010-03-17 Increasing the selectivity of the anticancer drug cyclophamide
GBGB1004712.4A Ceased GB201004712D0 (en) 2010-02-06 2010-03-22 Improvements in the chemotherapy of cancer
GBGB1004714.0A Ceased GB201004714D0 (en) 2010-02-06 2010-03-22 Chemotherapy of cancer and infectious diseases
GBGB1005204.1A Ceased GB201005204D0 (en) 2010-02-06 2010-03-29 Improvements in heterotypic formulations of anticancer drugs
GBGB1013592.9A Ceased GB201013592D0 (en) 2010-02-06 2010-08-13 Prophylactic preparations against sexually transmitted diseases
GBGB1013699.2A Ceased GB201013699D0 (en) 2010-02-06 2010-08-16 Methods for overcoming antibacterial drug resistance

Family Applications Before (11)

Application Number Title Priority Date Filing Date
GBGB1001959.4A Ceased GB201001959D0 (en) 2010-02-06 2010-02-06 Formulations of generic drugs against cancer and infectious diseases
GBGB1002941.1A Ceased GB201002941D0 (en) 2010-02-06 2010-02-22 Delaying the development of resistances to anticancer,antibacterial and some other drugs
GBGB1003119.3A Ceased GB201003119D0 (en) 2010-02-06 2010-02-24 Methods for delaying or overcoming bacterial drug resistance to beta-lactam and other antibiotics
GBGB1003116.9A Ceased GB201003116D0 (en) 2010-02-06 2010-02-24 Reversing resistance to anticancer, antibacterial and some other drugs
GBGB1003514.5A Ceased GB201003514D0 (en) 2010-02-06 2010-03-03 Improvements in antibacterial drugs
GBGB1003509.5A Ceased GB201003509D0 (en) 2010-02-06 2010-03-03 Delaying the development of resistances to anticancer,antibacterial and some other drugs
GBGB1003676.2A Ceased GB201003676D0 (en) 2010-02-06 2010-03-05 Overcoming beta-lactam drug resistance
GBGB1003782.8A Ceased GB201003782D0 (en) 2010-02-06 2010-03-08 A wide-spectrum chemotherapy of cancers and baterial diseases
GBGB1003935.2A Ceased GB201003935D0 (en) 2010-02-06 2010-03-10 Improvements in antibacterial drugs
GBGB1004209.1A Ceased GB201004209D0 (en) 2010-02-06 2010-03-15 Low toxic 5-fluorouracil chemotherapy
GBGB1004328.9A Ceased GB201004328D0 (en) 2010-02-06 2010-03-16 Increasing the efficacy of anticancer drugs

Family Applications After (5)

Application Number Title Priority Date Filing Date
GBGB1004712.4A Ceased GB201004712D0 (en) 2010-02-06 2010-03-22 Improvements in the chemotherapy of cancer
GBGB1004714.0A Ceased GB201004714D0 (en) 2010-02-06 2010-03-22 Chemotherapy of cancer and infectious diseases
GBGB1005204.1A Ceased GB201005204D0 (en) 2010-02-06 2010-03-29 Improvements in heterotypic formulations of anticancer drugs
GBGB1013592.9A Ceased GB201013592D0 (en) 2010-02-06 2010-08-13 Prophylactic preparations against sexually transmitted diseases
GBGB1013699.2A Ceased GB201013699D0 (en) 2010-02-06 2010-08-16 Methods for overcoming antibacterial drug resistance

Country Status (1)

Country Link
GB (17) GB201001959D0 (en)

Also Published As

Publication number Publication date
GB201003935D0 (en) 2010-05-12
GB201003782D0 (en) 2010-04-21
GB201003119D0 (en) 2010-04-14
GB201013699D0 (en) 2010-09-29
GB201003116D0 (en) 2010-04-14
GB201004209D0 (en) 2010-04-28
GB201004328D0 (en) 2010-04-28
GB201004712D0 (en) 2010-05-05
GB201003514D0 (en) 2010-04-21
GB201003676D0 (en) 2010-04-21
GB201013592D0 (en) 2010-09-29
GB201005204D0 (en) 2010-05-12
GB201003509D0 (en) 2010-04-21
GB201001959D0 (en) 2010-03-24
GB201004714D0 (en) 2010-05-05
GB201002941D0 (en) 2010-04-07

Similar Documents

Publication Publication Date Title
GB201008005D0 (en) Pharmaceutical compounds
HK1203811A1 (en) Anticancer agent
GB201205164D0 (en) Pharmaceutical compounds
HK1210451A1 (en) Capsule for the preparation of beverages
GB201020161D0 (en) Pharmaceutical compounds
EP2818870A4 (en) Combined anticancer drug sensitivity-determining marker
EP2837387A4 (en) Anticancer agent
WO2012042540A9 (en) Anticancer agent
EP2898882A4 (en) Medicine having improved rivastigmine stability
HK1216619A1 (en) Pharmaceutical compounds
EP2565192A4 (en) Anticancer agent
EP2564852A4 (en) Anti-brain-tumor drug
PL2394638T3 (en) New pharmaceutical combinations
HRP20141173T1 (en) Pharmaceutical comprising myramistin
ZA201300083B (en) New drug combinations for the treatment of malaria
GB201202027D0 (en) Pharmaceutical compounds
GB201004415D0 (en) Increasing the selectivity of the anticancer drug cyclophamide
ZA201400726B (en) Anticancer agent
EP2668961A4 (en) Combined pharmaceutical preparation
GB201209478D0 (en) Increasing the selectivity of the anticancer drug cyclophosphamide
ZA201301851B (en) Pharmaceutical combinations
GB201021361D0 (en) Pharmaceutical Compounds
GB201020366D0 (en) Pharmaceutical compounds
GB201020364D0 (en) Pharmaceutical compounds
GB201020068D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)